The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)

IBNSINA Revenue

The IBN SINA Pharmaceutical Industry had revenue of 2.55B BDT in the quarter ending March 31, 2024, with 26.26% growth. This brings the company's revenue in the last twelve months to 10.87B, up 24.73% year-over-year. In the fiscal year ending June 30, 2023, The IBN SINA Pharmaceutical Industry had annual revenue of 9.13B with 7.61% growth.

• Revenue (ttm): 10.87B
• Revenue Growth: +24.73%
• P/S Ratio: 0.99
• Revenue / Employee: 2.72M
• Employees: 4,000
• Market Cap: 10.81B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	9.13B	645.51M	7.61%
Jun 30, 2022	8.48B	1.10B	14.96%
Jun 30, 2021	7.38B	1.18B	19.13%
Jun 30, 2020	6.19B	927.67M	17.62%
Jun 30, 2019	5.26B	606.61M	13.02%